CMS Coverage Of Post-Approval Studies Seeks To Improve Data For NCDs
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to pay for carotid artery stenting with embolic protection in post-approval studies advances the agency's interest in efficiently gathering data to better inform national coverage determinations
You may also be interested in...
Carotid Stenting In Asymptomatic Patients Feared By UK Vascular Surgeon
Favorable reimbursement policies for carotid stenting may lead to inappropriate applications of the procedure, particularly in asymptomatic patients, according to UK device safety panelist Peter Bell, MD, University of Leicester
Carotid Stenting In Asymptomatic Patients Feared By UK Vascular Surgeon
Favorable reimbursement policies for carotid stenting may lead to inappropriate applications of the procedure, particularly in asymptomatic patients, according to UK device safety panelist Peter Bell, MD, University of Leicester
Medicare Will Cover PET To Distinguish Alzheimer’s From Other Dementia
CMS' decision to provide national coverage of FDG-PET imaging for some suspected dementia patients corresponds with the Neuroimaging Work Group of the Alzheimer's Association's consensus position